Last update:

Medical economics news

Obstetrics & gynaecology

Insurance-related disparities seen in prenatal diagnosis of congenital heart disease

Second-trimester ultrasound receipt mediates a considerable portion of the association between public insurance and prenatal diagnosis of congenital heart disease (CHD), according to a study published online Sept. 23 in Prenatal ...

Medical economics

Findings call for transparency in Medicare Advantage operations

New findings call for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest health care capitation program.

HIV & AIDS

Study finds telehealth effective for HIV patients

A Rutgers Health study suggests telehealth could be a viable long-term option for people living with HIV, potentially saving them time, effort and expense related to in-person medical visits.

Health

The Medicare Advantage influence machine

Federal officials resolved more than a decade ago to crack down on whopping government overpayments to private Medicare Advantage health insurance plans, which were siphoning off billions of tax dollars every year.

Psychology & Psychiatry

How marijuana taxes could fund mental health care for millions

Research by GPH's Jonathan Purtle says that earmarking state taxes on recreational sales is an underused strategy for financing mobile psychiatric crisis units, the National Suicide Prevention Lifeline, and more.

Medications

Use of extrapolation common in FDA new drug approvals

Extrapolation from pivotal trial data to broader U.S. Food and Drug Administration (FDA)-approved indications is common, according to a study published online April 19 in JAMA Network Open.

Pediatrics

Role of race in calculating UTI risk in children reassessed

The variable race is associated with urinary tract infection (UTI) in children, but it can be replaced with history of UTI and duration of fever in a previously developed prediction tool, according to a review published online ...

Oncology & Cancer

Most cancer centers do not disclose payer-specific prices

Most U.S. National Cancer Institute-designated cancer centers do not provide required price transparency, but markup on parenteral chemotherapy appears widespread, according to a study published online April 18 in JAMA Internal ...